Free Newsletter
Sleep study could boost some statins
If simvastatin (Zocor) can cause insomnia and nightmares as a new study shows, then why doesn't pravastatin (Pravachol)? It seems that Zocor and its rivals Lipitor, Mevacor, and Vytorin are fat soluble, and so they cross into the brain easily. Pravachol, Crestor, and Lescol which are water-soluble, don't.
So perhaps AstraZeneca can latch onto this study as a marketing tool for Crestor, since it lost out with its big heart failure study earlier this week. You'll recall that the company's CORONA project, intended to show that Crestor could help patients with heart failure, didn't exactly deliver. Too bad Lipitor is on the Zocor side of the insomnia divide. A good night's sleep could have been a selling point for the Pfizer blockbuster, which has been losing patients to the newly generic simvastatin by the thousands.
- see the American Heart Association release
- check out this report
- read more about the way statins sneak into the brain from WebMD
Related Articles:
Tossing and turning? Maybe it's the Zocor
Zocor feeling the heat from generics
AZ's Crestor flubs key heart failure trial
Switching to generic statins not so healthy
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





